Happenings
Mar 17, 2025
All eyes are on Alnylam as the company awaits entry into the transthyretin amyloid cardiomyopathy market, which currently includes Pfizer and BridgeBio and is…
Feb 25, 2025
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, is hosting an R&D Day today in New York…
Feb 25, 2025
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, is hosting an R&D Day today in New York…
Jan 10, 2025
ARC welcomed Jan Griffin, MD, amyloidosis cardiologist at the Medical University of South Carolina. Dr. Griffin discussed how ATTR affects the heart and explored…
Jun 18, 2024
Who: Alnylam Patient Education Liaison, Karen, joined by Ambassador, Jean, living with hATTR amyloidosis and Sonia Caraballo-Cartagena, MD Neuromuscular…
Apr 27, 2024
When:
Saturday, April 27, 2024
AL will meet in the AM-Registration: 8:00-8:30AM
ATTR will meet in the PM-Registration: 11:30-12:30PM
Where:
Goldberg Auditorium…
Apr 20, 2024
When:
Saturday, April 20, 2024
AL will meet in the AM-Registration: 8:00-8:30AM
ATTR will meet in the PM-Registration: 11:30-12:30PM
Where:
Rood Pavilion…
Apr 20, 2024
When:
Saturday, April 20, 2024
AL will meet in the AM-Registration: 8:30-9:00AM
ATTR will meet in the PM-Registration: 11:30-12:30PM
Where:
Reform Congregation…
Apr 20, 2024
If you are from Kansas, Nebraska, Missouri, Iowa, Arkansas, Oklahoma, or anywhere else, know you are welcome.
When:
Saturday, April 20, 2024
AL will meet in the…
Mar 01, 2024
"Light the Night for Amyloidosis" is an Amyloidosis Foundation awareness campaign created to draw attention to amyloidosis symptoms, diagnosis, treatment and…